NZ HIV Medicine Research Review Issue 47

In this issue:
  -  Sudden cardiac death and myocardial fibrosis in HIV
  -  HIV PrEP across Australian clinics
  -  Time spent with HIV-RNA ≤200 copies/mL in the U=U era
  -  Low HCV in PrEP users: contribution of sexual transmission
  -  Routine syphilis screening in men with HIV
  -  Long-term HIV protection with PrEP in gay/bisexual men
  -  Targeted testing and immediate initiation of acute HIV treatment in MSM
  -  Emtricitabine with TAF or TDF for HIV-1 PrEP
  -  Dolutegravir/lamivudine in test-and-treat setting for newly diagnosed HIV
  -  COVID vaccination (AstraZeneca) in patients with HIV

Please login below to download this issue (PDF)